Modern medicine is putting more pressure on the transition from the old paradigm of population medicine to the new concepts of PRECISION MEDICINE. These new concepts require precise delivery of therapies. The goal of Ti-com is to build a platform for the delivery of therapeutic agents based on biomaterials and image-guided neurointerventions to achieve unprecedented precision and reproducibility.
VISION

OUR OFFER
OURTEAM
SCIENTIFICADVISORYBOARD
Prof. Johannes Boltze
University of Warwick, UK
Prof. Tim Magnus
University Medical Center, Hamburg, Germany
Prof. Miguel Oliveira
University of Minho, Portugal
20 year of academic experience in modeling neurological disease in large animals and strong industry connections
Deputy Director, Department of Neurology University of Hamburg, world leader in the field of stroke
Vice President of I3Bs with expertise in novel classes of biomaterials for applications in biomedicine
Mr. Terje Svendsen
Prof. Dileep Raghvendra Yavagal
Prof. Jesús Ruiz-Cabello
NovaMatrix, Norway
University of Miami, USA
CIC biomaGUNE, Spain
With his in depth knowledge in alginate hydrogel product development he helps guide Ti-com in marketing their advanced biomaterials.
Chief of Interventional Neurology offers his unique perspective and understands the needs of modern endovascular therapies of neurological disorders
Imaging scientist with particular interest in MRI and nuclear medicine